5
Oct 22
Payback mechanism for medical devices in light of the Aiuti-bis Decree
On September 22, Law No. 142/2022 converting Decree-Law No. 115 of August 9, 2022 (the “Aiuti-bis Decree”) was published.
5
Oct 22
The new standards for territorial care and telemedicine services in accordance with Ministerial Decree 77/2022
On June 22, 2022, the decree of the Ministry of Health No. 77 on “Models and standards for the development of territorial care in the National Health Service” (the “Document”) was published in the Official Gazette.
6
Jul 22
Clinical trials and pharmacovigilance: Spanish Code of Conduct leads the way in data management
In an effort to expand the regulatory framework with self-regulatory instruments, the Spanish Data Protection Authority recently approved a “Code of conduct for the processing of personal data in the field of clinical trials and other clinical research and of pharmacovigilance” supported by Farmaindustria, the national trade association for the pharmaceutical industry in Spain.
6
Jul 22
<!--:it-->Draft EMA guidelines on transparency in clinical trials: Protecting commercially confidential information<!--:-->
On April 7, 2022, the EMA published draft guidelines on the transparency of information uploaded to the Clinical Trial Information System for the specific purpose of giving operational guidance on the management of commercially confidential information and personal data
